ELAN

#826
Elanco Animal Health Incorporated Common Stock
23.2300 USD
+0.04%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
23.1200
23.2650
Year Range
20.4100
27.7200
Daily Change
+0.04%
Monthly Change
-1.55%
6 month change
+3.73%
Year Change
+3.73%
Previous Close
23.2200
Open
23.2650
Bid
Ask
Low
23.1200
High
23.2650
Volume
359
Open full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 11.5492 B
  • Employee 9 900
  • Founded N/A
  • CEO Jeffrey N. Simmons
  • Website www.elanco.com
  • Headquarter Indiana, United States
  • FIGI BBG00LJYS1P8
  • Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-48.15
Price to sales ratio
2.5

Elanco Animal Health Incorporated

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.

News